Diagnosis and Management of Hypertrophic Cardiomyopathy and Prevention of Sudden Death: The Next 50 Years International Summit IV

Barry J. Maron, MD
Summit Director

Dates:	Friday – Sunday, October 16 – 18, 2009
Location:	Hyatt Regency on Nicollet Mall Minneapolis, Minnesota, USA
Supported by:	Unrestricted educational grants from: Boston Scientific Medtronic, Inc. St. Jude Medical
Presented by:

Online Registration

To Register, click on this link: http://hcm.eventbrite.com/

Summit Description

This summit will provide attendees with an opportunity to learn the clinical, morphologic and genetic spectrum of hypertrophic cardiomyopathy (HCM) from a world-renowned faculty. The program will explore the diverse views on the natural history and assessment of risk for sudden death.

Who Should Attend

• Practicing cardiologists, internists, pediatricians and other health care professionals with an interest in HCM.
• Clinicians and basic researchers directly involved with cardiomyopathies.

Summit Objectives

• Identify the clinical, morphologic and genetic spectrum of HCM.
• Explore the diverse views on the natural history and assessment of risk for sudden death.
• Review contemporary management strategies for high-risk and other patient subgroups, including surgical septal myectomy, alcohol septal ablation, pacing, and prevention of sudden death with implantable defibrillators.
• Assess and determine appropriate management of heart failure and arrhythmias, including atrial fibrillation and ventricular tachyarrhythmia.
• Identify mechanisms responsible for adverse clinical events and natural history.
• Learn the role of new diagnostic modalities including magnetic resonance imaging (MRI), positron emission tomography (PET), and advanced echocardiographic techniques.
• Understand the significance and occurrence of left ventricular outflow obstruction.
• Learn to detect and profile HCM in athletic populations.

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Allina Hospitals & Clinics and Minneapolis Heart Institute Foundation. Allina Hospitals & Clinics is accredited by the ACCME to provide continuing medical education for physicians.

The Center for Learning & Innovation, Office of Accreditation at Allina Hospitals & Clinics designates this educational activity for a maximum of 20.25 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The Center for Learning & Innovation, Office of Accreditation at Allina Hospitals & Clinics is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Participants can earn up to 20.25 nursing contact hours.

Individuals representing other professional disciplines may submit summit materials to their respective professional associations for 20.25 hours of continuing education credit.

Acknowledgements

Minneapolis Heart Institute Foundation wishes to thank the following companies for unrestricted educational grants providing major support for this summit:

We also wish to acknowledge the following companies for unrestricted educational grants in support of this summit:

• GeneDx, a subsidiary of Bio-Reference Laboratories, Inc.
• Minneapolis Cardiology Associates
• PGxHealth, a division of Clinical Data, Inc.
• BIOTRONIK, Inc.
• Correlagen Diagnostics, Inc.